ArticleThe Lancet regional health. Europe2022
Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.
Article in The Lancet regional health. Europe, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Article
- The use of quarantine as an international travel measure during the COVID-19 pandemic: A comparative analysis of implementation and equity impacts in five "exemplar" countries.PLOS global public health · 2025Article
- COVID-19 passenger screening to reduce travel risk and translocation of disease.Epidemiology and infection · 2024Article
- Geographical and practical challenges in the implementation of digital health passports for cross-border COVID-19 pandemic management: a narrative review and framework for solutions.Globalization and health · 2023Review
- The Impact of Entry Restrictions on the Spread of Severe Acute Respiratory Syndrome Coronavirus Variants Between 2021 and 2022.Journal of Korean medical science · 2023Article
- Border Control for Infectious Respiratory Disease Pandemics: A Modelling Study for H1N1 and Four Strains of SARS-CoV-2.Viruses · 2023Article
- Lessons from the Lab: SARS-CoV-2 Detection Rate amongst the Vaccinated Travel Lane and Non-Vaccinated Travel Lane Travellers into Malaysia.The Malaysian journal of medical sciences : MJMS · 2023Article
- The COVID-19 pandemic in various restriction policy scenarios based on the dynamic social contact rate.Heliyon · 2023Article
- Cost benefit analysis of alternative testing and quarantine policies for travelers for infection control: A case study of Singapore during the COVID-19 pandemic.Frontiers in public health · 2023Article
- Economic evaluation of COVID-19 rapid antigen screening programs in the workplace.BMC medicine · 2022Article
- Drivers and forecasts of multiple waves of the coronavirus disease 2019 pandemic: A systematic analysis based on an interpretable machine learning framework.Transboundary and emerging diseases · 2022Article
- Quarantine and serial testing for variants of SARS-CoV-2 with benefits of vaccination and boosting on consequent control of COVID-19.PNAS nexus · 2022Article
- Article
- Navigating travel in Europe during the pandemic: from mobile apps, certificates and quarantine to traffic-light system.Journal of travel medicine · 2022Article
- Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.The Lancet regional health. Europe · 2022Article
- Global Health Needs Modernized Containment Strategies to Prepare for the Next Pandemic.Frontiers in public health · 2022Article
- Testing for COVID-19 is Much More Effective When Performed Immediately Prior to Social Mixing.International journal of public health · 2022Article
- Quarantine and testing strategies to ameliorate transmission due to travel during the COVID-19 pandemic: a modelling study.medRxiv : the preprint server for health sciences · 2021Article
- Modeling approaches to inform travel-related policies for COVID-19 containment: A scoping review and future directions.Travel medicine and infectious diseaseArticle
Corrections and comments
- Update of
Authors and funding
8 authors.
Funding
Abstract
backgroundNumerous countries have imposed strict travel restrictions during the COVID-19 pandemic, contributing to a large socioeconomic burden. The long quarantines that have been applied to contacts of cases may be excessive for travel policy.
methodsWe developed an approach to evaluate imminent countrywide COVID-19 infections after 0-14-day quarantine and testing. We identified the minimum travel quarantine duration such that the infection rate within the destination country did not increase compared to a travel ban, defining this minimum quarantine as "sufficient."
findingsWe present a generalised analytical framework and a specific case study of the epidemic situation on November 21, 2021, for application to 26 European countries. For most origin-destination country pairs, a three-day or shorter quarantine with RT-PCR or antigen testing on exit suffices. Adaptation to the European Union traffic-light risk stratification provided a simplified policy tool. Our analytical approach provides guidance for travel policy during all phases of pandemic diseases.
interpretationFor nearly half of origin-destination country pairs analysed, travel can be permitted in the absence of quarantine and testing. For the majority of pairs requiring controls, a short quarantine with testing could be as effective as a complete travel ban. The estimated travel quarantine durations are substantially shorter than those specified for traced contacts.
fundingEasyJet (JPT and APG), the Elihu endowment (JPT), the Burnett and Stender families' endowment (APG), the Notsew Orm Sands Foundation (JPT and APG), the National Institutes of Health (MCF), Canadian Institutes of Health Research (SMM) and Natural Sciences and Engineering Research Council of Canada EIDM-MfPH (SMM).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.